April 13, 2016 / 11:12 AM / a year ago

BUZZ-Valeant Pharmaceuticals: Gets notice of default from bondholders

** Canadian drugmaker’s U.S.-listed shares down 2.5 pct at $31.50

** Says got a notice of default from bondholders as a result of a delay filing its annual report

** Centerbridge Partners LP issued the notice, but it is not expected to lead to a default, people familiar with the matter told Reuters

** Valeant said has until June 11 to make the filing, under its bond agreements, but reiterated its intention to file it on or before April 29

** “The noteholders may have just been attempting to protect themselves from any further filing delays,” Reorg Research Senior Covenant Analyst Saish Setty says

** Up to Tuesday’s close, stock had fallen 68 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below